F2RL3
F2RL3 (also known as Proteinase-activated receptor 4) is a protein that in humans is encoded by the F2RL3 gene. This protein is a member of the protease-activated receptor (PAR) family, which is a subfamily of related G protein-coupled receptors (GPCRs).
Function[edit | edit source]
F2RL3 is activated by thrombin and trypsin, but not by plasmin or Factor Xa. It is suggested to be involved in platelet activation and regulates angiogenesis in endothelial cells. Thrombin significantly promotes the proliferation and the migration of endothelial cells via the activation of F2RL3.
Clinical significance[edit | edit source]
Alterations in the F2RL3 gene have been associated with a variety of diseases, including cancer, cardiovascular disease, and inflammation. Methylation of the F2RL3 gene has been proposed as a potential biomarker for lung cancer and cardiovascular disease risk.
Structure[edit | edit source]
The F2RL3 protein is a seven-transmembrane protein, typical of G protein-coupled receptors. The gene encoding this protein is approximately 12 kb in length and is made up of two exons. The sequence of the intron is highly conserved among different species, suggesting a possible functional significance.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
- F2RL3 at the National Center for Biotechnology Information
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD